🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.

Several experts stated the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Material Elimination

According to the social media company, the service has taken down violative content and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.

After moments of entering one community, a vendor shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these groups, posts show black plastic parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to potentially significant medical dangers”.